NovoCure Ltd (NVCR)
22.17
+1.12
(+5.32%)
USD |
NASDAQ |
May 16, 16:00
22.18
+0.02
(+0.07%)
After-Hours: 20:00
NovoCure Gross Profit Margin (Quarterly): 75.68% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 75.68% |
December 31, 2023 | 75.67% |
September 30, 2023 | 74.79% |
June 30, 2023 | 73.01% |
March 31, 2023 | 75.76% |
December 31, 2022 | 77.51% |
September 30, 2022 | 77.29% |
June 30, 2022 | 79.77% |
March 31, 2022 | 79.84% |
December 31, 2021 | 77.71% |
September 30, 2021 | 77.39% |
June 30, 2021 | 78.58% |
March 31, 2021 | 80.41% |
December 31, 2020 | 80.45% |
September 30, 2020 | 78.60% |
June 30, 2020 | 78.03% |
March 31, 2020 | 75.94% |
December 31, 2019 | 75.02% |
September 30, 2019 | 75.13% |
June 30, 2019 | 75.66% |
Date | Value |
---|---|
March 31, 2019 | 72.97% |
December 31, 2018 | 66.95% |
September 30, 2018 | 70.74% |
June 30, 2018 | 67.76% |
March 31, 2018 | 65.01% |
December 31, 2017 | 70.85% |
September 30, 2017 | 69.76% |
June 30, 2017 | 65.73% |
March 31, 2017 | 66.56% |
December 31, 2016 | 63.72% |
September 30, 2016 | 48.70% |
June 30, 2016 | 9.54% |
March 31, 2016 | 38.85% |
December 31, 2015 | 49.09% |
September 30, 2015 | 36.79% |
June 30, 2015 | 27.40% |
March 31, 2015 | 25.17% |
December 31, 2014 | 30.81% |
September 30, 2014 | 40.88% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
73.01%
Minimum
Jun 2023
80.45%
Maximum
Dec 2020
77.11%
Average
77.34%
Median
Gross Profit Margin (Quarterly) Benchmarks
AtriCure Inc | 74.66% |
NeuroMetrix Inc | 64.35% |
Repligen Corp | 49.53% |
Teleflex Inc | 56.40% |
Perspective Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -49.08% |
Return on Assets | -16.77% |
Return on Invested Capital | -20.06% |
Profit Margin (Quarterly) | -27.98% |
Operating Margin (Quarterly) | -29.98% |
Return on Net Operating Assets | -85.36% |